APA (7. basım) Alıntı

Krendyukov, A., Kneisel, N., Zhu, J., Merz, C., Richards, D., Gieffers, C., . . . Mitchell, T. (2020). The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP model. Elsevier.

Chicago Style (17. basım) Atıf

Krendyukov, A., N. Kneisel, J. Zhu, C. Merz, D. Richards, C. Gieffers, B. Van Den Eynde, ve T. Mitchell. The Role of Asunercept as a Selective CD95L Inhibitor in Cutaneous Melanoma: Rationale and Results from an Enhanced TiRP Model. Elsevier, 2020.

MLA (9th ed.) Atıf

Krendyukov, A., et al. The Role of Asunercept as a Selective CD95L Inhibitor in Cutaneous Melanoma: Rationale and Results from an Enhanced TiRP Model. Elsevier, 2020.